JAMA Internal Medicine commentary highlights opportunity to discover modifiable risk factors for dementia In a commentary published in JAMA Internal Medicine, three Regenstrief Institute research scientists write that while they and other researchers have identified a strong and consistent link between anticholinergic drugs and cognitive impairment from observational studies, randomized clinical trials represent the only […]
By Gregory Schmidt, MD & Theresa Cullen, MD, MS Healthcare in America is a pairing of extremes. When ranked, the United States has some of the very best and the very worst healthcare metrics. Cancer survival remains the highest of any country, yet maternal deaths and infant deaths rank the worst of all developed nations. […]
Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., shared his passion for biomedical informatics as part of a video series highlighting the journeys of graduates from National Library of Medicine T15 training programs.